D17. Acetylcholinesterase inhibitors with a known history of persistent bradycardia (<60 beats/min.), heart block, or recurrent unexplained syncope (risk of cardiac conduction failure, syncope, and injury). This evidence concerns the gene ACHE and Heart block.